Literature DB >> 16468740

Enantioselective total synthesis of convolutamydines B and E.

Tomoaki Nakamura1, Shin-ichi Shirokawa, Seijiro Hosokawa, Atsuo Nakazaki, Susumu Kobayashi.   

Abstract

[reaction: see text] The first enantioselective total synthesis of convolutamydines B and E has been achieved using our vinylogous Mukaiyama aldol reaction. The synthesis features highly diastereoselective vinylogous Mukaiyama aldol reaction with isatin instead of aldehydes to construct a chiral center of convolutamydines. Additionally, the absolute configuration of natural convolutamydine B has been determined as R by its CD spectrum.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16468740     DOI: 10.1021/ol052871p

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Highly enantioselective catalytic benzoyloxylation of 3-aryloxindoles using chiral VAPOL calcium phosphate.

Authors:  Zuhui Zhang; Wenhua Zheng; Jon C Antilla
Journal:  Angew Chem Int Ed Engl       Date:  2010-12-22       Impact factor: 15.336

2.  Three-component coupling reactions of silyl glyoxylates, vinyl Grignard reagent, and nitroalkenes: an efficient, highly diastereoselective approach to nitrocyclopentanols.

Authors:  Gregory R Boyce; Jeffrey S Johnson
Journal:  Angew Chem Int Ed Engl       Date:  2010-11-15       Impact factor: 15.336

3.  New Metabolites from Endophytic Fungus Chaetomium globosum CDW7.

Authors:  Wei Yan; Ling-Ling Cao; Yang-Yang Zhang; Ran Zhao; Shuang-Shuang Zhao; Babar Khan; Yong-Hao Ye
Journal:  Molecules       Date:  2018-11-04       Impact factor: 4.411

4.  Cu(ii)-thiophene-2,5-bis(amino-alcohol) mediated asymmetric Aldol reaction and Domino Knoevenagel Michael cyclization: a new highly efficient Lewis acid catalyst.

Authors:  Abdullah Mohammed Al-Majid; Abdullah Saleh Alammari; Saeed Alshahrani; Matti Haukka; Mohammad Shahidul Islam; Assem Barakat
Journal:  RSC Adv       Date:  2022-02-21       Impact factor: 3.361

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.